Press Release: Nirsevimab delivers 83% reduction in RSV infant hospitalizations in a real-world clinical trial setting sanofi.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sanofi.com Daily Mail and Mail on Sunday newspapers.
Nirsevimab delivers 83% reduction in RSV infant hospitalizations in a real-world clinical trial setting HARMONIE Phase 3b data reinforce nirsevimab’s consistent and high efficacy against infant hospitalizations due to RSVData presented at ESPID add to the body of evidence demonstrating nirsevi.
Vaccinating women in pregnancy can protect women and their infants from infectious diseases. This intervention is increasingly recognised as a safe and effective way to reduce infant morbidity and mortality.
Masks come down, respiratory infections go up for young kids Asia News Network (ANN) is the leading regional alliance of news titles striving to bring the region closer, through an active sharing of editorial content on happenings in the region.